# Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach

> **NCT02696733** · PHASE4 · UNKNOWN · sponsor: **Medical University of Warsaw** · enrollment: 100 (estimated)

## Conditions studied

- Urinary Bladder Neoplasms
- Transurethral Resection
- Nerve Block

## Interventions

- **DEVICE:** Ultrasound
- **DRUG:** lidocaine 2%
- **DRUG:** 0.9% Natrium Chloratum with a 2nd generation cephalosporin

## Key facts

- **NCT ID:** NCT02696733
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02696733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02696733, "Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02696733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*